Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#181 / 200 Total
AUID - authID Inc - Stock Price Chart
TickerAUID [NASD]
CompanyauthID Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap71.06MEPS (ttm)-19.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y10.66%
P/S374.02EPS next 5Y-
P/B5.38EPS Q/Q82.28%
Dividend-Sales Q/Q-72.96%
Insider Own18.55%Inst Own12.65%
Insider Trans17.09%Inst Trans-41.48%
Short Float3.65%EarningsMar 20/a
Analyst Recom-Target Price-
Avg Volume25.98K52W Range2.45 - 13.63
Apr-18-24 08:00AM authID Selected by National Notarial Centralized Verification System For Secure Biometric Identity Assurance (GlobeNewswire)
Apr-02-24 08:00AM authID Announces Key Customer Launches in Q1 (GlobeNewswire)
Mar-26-24 08:34AM authID Inc. (NASDAQ:AUID) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:00AM Leading Biometric Identify Verification & Authentication Firm authID Inc. Appoints Kunal Mehta to its Board of Directors (GlobeNewswire)
Mar-20-24 08:54PM AUID Stock Earnings: AuthID Reported Results for Q4 2023 (InvestorPlace)
04:00PM authID Inc. Reports Financial and Operating Results for the Fiscal Year Ended December 31, 2023 (GlobeNewswire)
Mar-13-24 08:00AM authID and Verified Inc. Partner to Launch 1-Click Identity Verification (GlobeNewswire)
Mar-05-24 08:00AM authID to Report Fiscal Year 2023 Financial Results on March 20, 2024 (GlobeNewswire)
Feb-22-24 08:00AM authID Inc. Announces Change to its Board of Directors for Next Phase of Growth (GlobeNewswire)
Feb-08-24 08:00AM authID Positions for Strong Growth in Biometric Identity Verification and Authentication with New Identity Domain Talent (GlobeNewswire)
HEPA - Hepion Pharmaceuticals Inc - Stock Price Chart
TickerHEPA [NASD]
CompanyHepion Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap7.49MEPS (ttm)-12.32
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y63.67%
P/S-EPS next 5Y-
P/B1.18EPS Q/Q7.17%
Dividend-Sales Q/Q-
Insider Own1.42%Inst Own13.65%
Insider Trans6.88%Inst Trans-42.30%
Short Float1.19%Earnings-
Analyst Recom3.00Target Price22.00
Avg Volume79.54K52W Range1.22 - 20.66
Apr-22-24 08:56AM Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today? (InvestorPlace) -29.85%
Apr-19-24 04:30PM Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial (GlobeNewswire)
Apr-16-24 11:52PM HEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023 (InvestorPlace) -6.42%
Mar-06-24 08:30AM Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell (GlobeNewswire) -11.92%
Feb-16-24 08:00AM Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds (GlobeNewswire) -5.19%
Jan-03-24 05:15PM Hepion Pharmaceuticals to Present at NASH-TAG 2024 (GlobeNewswire)
Dec-07-23 08:00AM Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes (GlobeNewswire) -5.56%
Nov-28-23 04:15PM Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit (GlobeNewswire)
Nov-13-23 04:05PM Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease (GlobeNewswire) +13.82%
Nov-10-23 08:50AM Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 'ALTITUDE-NASH' Liver Function Trial of Rencofilstat (GlobeNewswire)
LPTX - Leap Therapeutics Inc - Stock Price Chart
TickerLPTX [NASD]
CompanyLeap Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap83.20MEPS (ttm)-5.12
P/E-EPS this Y43.40%
Forward P/E-EPS next Y33.85%
PEG-EPS past 5Y28.36%
P/S-EPS next 5Y-2.49%
P/B1.38EPS Q/Q56.78%
Dividend-Sales Q/Q-
Insider Own29.27%Inst Own23.97%
Insider Trans0.00%Inst Trans-3.45%
Short Float8.01%EarningsMar 18/b
Analyst Recom1.40Target Price11.80
Avg Volume319.37K52W Range1.24 - 10.20
Apr-11-24 08:30AM Leap Therapeutics Announces $40 Million Private Placement (PR Newswire)
Mar-20-24 09:35AM Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks (Zacks) +15.91%
Mar-18-24 07:00AM Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Jan-16-24 05:05PM Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium (PR Newswire)
Jan-03-24 07:00AM Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-02-24 07:00AM Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients (PR Newswire) +12.67%
Dec-11-23 04:05PM Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium (PR Newswire)
Nov-21-23 07:00AM Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference (PR Newswire) +17.87%
Nov-13-23 07:00AM Leap Therapeutics Reports Third Quarter 2023 Financial Results (PR Newswire)
Oct-24-23 12:30PM 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis (ACCESSWIRE)
MI - NFT Ltd. - Stock Price Chart
TickerMI [AMEX]
CompanyNFT Ltd.
CountryHong Kong
IndustryInternet Retail
Market Cap2.47MEPS (ttm)4.92
P/E0.72EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-34.54%
P/S0.62EPS next 5Y-
P/B0.04EPS Q/Q233.45%
Dividend-Sales Q/Q-17.20%
Insider Own8.57%Inst Own0.63%
Insider Trans0.00%Inst Trans-
Short Float0.42%Earnings-
Analyst Recom-Target Price-
Avg Volume19.76K52W Range3.42 - 41.00
Apr-11-24 04:05PM NFT LTD. ANNOUNCES 1 FOR 50 REVERSE SHARE SPLIT (GlobeNewswire)
Nov-16-23 12:15PM RLH Equity Partners Announces Expanded Role for Rob Rodin (PR Newswire)
Sep-22-23 04:05PM NFT LTD. ANNOUNCES RECEIPT OF NYSE AMERICAN CONTINUED LISTING STANDARD NONCOMPLIANCE NOTICE (GlobeNewswire) -7.11%
Jan-25-23 04:05PM Takung Art Receives Notice of Noncompliance from NYSE American Exchange (GlobeNewswire)
Sep-16-22 06:06AM 3 Best NFT Stocks to Buy Now (InvestorPlace) -7.35%
May-05-22 05:00PM TKAT Provides Update of the NFT Trading Platform (GlobeNewswire) -7.76%
Apr-29-22 08:30AM TKAT announces launch of NFT trading website (GlobeNewswire)
Jan-11-22 01:07PM NFT Stocks List 2022: 10 Names to Know to Play the Non-Fungible Tokens Boom (InvestorPlace) +6.25%
Jan-07-22 04:50PM Takung Art Co., Ltd Announces Management Update (GlobeNewswire)
Dec-29-21 02:37PM Chinese Penny Stocks: What Is Going on With CPOP, TKAT, NEW Stocks Today? (InvestorPlace) +36.75%
SYPR - Sypris Solutions, Inc. - Stock Price Chart
TickerSYPR [NASD]
CompanySypris Solutions, Inc.
CountryUSA
IndustryAuto Parts
Market Cap31.36MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y15.64%
P/S0.23EPS next 5Y8.00%
P/B1.40EPS Q/Q-868.75%
Dividend-Sales Q/Q16.91%
Insider Own46.73%Inst Own45.32%
Insider Trans0.00%Inst Trans143.01%
Short Float4.65%EarningsApr 01/b
Analyst Recom3.00Target Price1.25
Avg Volume28.61K52W Range1.38 - 2.30
Apr-01-24 02:53PM SYPR Stock Earnings: Sypris Solutions Reported Results for Q4 2023 (InvestorPlace)
07:45AM Sypris Reports Fourth Quarter Results (Business Wire)
Mar-13-24 01:06PM KILL Sypris Wins Award for the Gorgon Project in Western Australia (Business Wire)
Nov-20-23 01:35PM Sypris Solutions, Inc. (NASDAQ:SYPR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-15-23 07:45AM Sypris Reports Third Quarter Results (Business Wire)
Nov-13-23 03:30PM Sypris Solutions, Inc. to Announce Third Quarter Financial Results, Host Conference Call and Webcast November 15 (GlobeNewswire)
08:30AM Sypris Wins Award for Cryptographic Program (Business Wire)
Nov-06-23 08:30AM Sypris Wins Two Follow-On Contract Awards for Electronic Warfare Communications and Navigation Program (Business Wire)
Aug-15-23 10:40PM Q2 2023 Sypris Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
07:45AM Sypris Reports Second Quarter Results (Business Wire)
BYSI - BeyondSpring Inc - Stock Price Chart
TickerBYSI [NASD]
CompanyBeyondSpring Inc
CountryUSA
IndustryBiotechnology
Market Cap83.11MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y28.00%
P/S-EPS next 5Y-
P/B-EPS Q/Q52.99%
Dividend-Sales Q/Q87.78%
Insider Own39.17%Inst Own1.30%
Insider Trans0.00%Inst Trans-20.52%
Short Float10.09%Earnings-
Analyst Recom2.00Target Price1.25
Avg Volume223.84K52W Range0.65 - 4.00
Mar-25-24 07:00AM BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer (GlobeNewswire) +11.22%
Feb-26-24 08:00AM BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements (GlobeNewswire) +9.17%
Jan-10-24 03:00PM BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K (GlobeNewswire)
Dec-18-23 04:30PM BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements (GlobeNewswire)
Nov-07-23 07:00AM BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors (GlobeNewswire)
Oct-31-23 08:00AM BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin's Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models (GlobeNewswire)
Oct-30-23 08:00AM BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Oct-26-23 08:30AM SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at Targeted Protein Degradation Think Tank Symposium (GlobeNewswire) -5.36%
Oct-23-23 07:45AM SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors (GlobeNewswire)
Oct-04-23 03:55PM BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements (GlobeNewswire)
MRT - Marti Technologies Inc. - Stock Price Chart
TickerMRT [AMEX]
CompanyMarti Technologies Inc.
CountryTurkey
IndustrySoftware - Application
Market Cap72.86MEPS (ttm)0.07
P/E22.29EPS this Y4.48%
Forward P/E-EPS next Y29.69%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.19EPS Q/Q248.15%
Dividend-Sales Q/Q-
Insider Own72.46%Inst Own4.71%
Insider Trans0.00%Inst Trans0.67%
Short Float1.91%EarningsApr 16/b
Analyst Recom1.00Target Price1.40
Avg Volume226.20K52W Range0.44 - 17.72
Apr-25-24 08:16AM Marti Announces Amendment to up to $2.5M Share Repurchase Program (Business Wire) -6.54%
Apr-24-24 09:37AM Martis Ride-Hailing Service Reaches Over 788,000 Riders and Over 145,000 Registered Drivers (Business Wire) +6.99%
Apr-16-24 09:09AM Marti Announces Full Year 2023 Results (Business Wire) +12.31%
Apr-12-24 04:21PM Marti Technologies, Inc. to Report Full Year 2023 Results on April 16, 2024 (Business Wire)
Feb-28-24 08:00AM Marti Launches Taxi-Hailing Service as Its Sixth Urban Transportation Modality (Business Wire)
Feb-05-24 07:00AM Marti Acquires Zobas AI-Powered Optimization Platform to Increase Ridership and Reduce Operational Costs (Business Wire) -7.48%
Jan-29-24 07:00AM Marti introduces multi-modal subscription packages to increase rider usage and improve the operational efficiency of its two-wheeled electric vehicle business (Business Wire)
Jan-16-24 08:47AM Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-10-24 04:09PM Marti Announces up to $2.5M Share Repurchase Program (Business Wire)
Jan-05-24 07:00AM Marti Announces Completion of Redemption of Outstanding Warrants (Business Wire)
OCEA - Ocean Biomedical Inc. - Stock Price Chart
TickerOCEA [NASD, RUT]
CompanyOcean Biomedical Inc.
CountryUSA
IndustryBiotechnology
Market Cap46.43MEPS (ttm)-3.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-587.66%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own13.49%
Insider Trans0.00%Inst Trans2.64%
Short Float7.39%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume6.80M52W Range0.52 - 12.08
Apr-24-24 04:51PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K (GlobeNewswire)
Mar-28-24 01:15PM 13 Hot Stocks to Invest in According to Wall Street Analysts (Insider Monkey) -6.77%
08:01AM Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL (GlobeNewswire)
Mar-24-24 03:52PM 5 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-05-24 08:30AM Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments (GlobeNewswire) +28.92%
Feb-29-24 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting (GlobeNewswire) +14.29%
Dec-05-23 09:45AM EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody (Benzinga)
08:15AM Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody (GlobeNewswire)
Nov-29-23 05:41PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) -8.95%
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
WW - WW International Inc - Stock Price Chart
TickerWW [NASD, RUT]
CompanyWW International Inc
CountryUSA
IndustryPersonal Services
Market Cap138.60MEPS (ttm)-1.61
P/E-EPS this Y-23.07%
Forward P/E6.18EPS next Y309.04%
PEG-EPS past 5Y-
P/S0.16EPS next 5Y15.00%
P/B-EPS Q/Q-141.68%
Dividend-Sales Q/Q-8.02%
Insider Own1.45%Inst Own83.52%
Insider Trans-3.84%Inst Trans-5.92%
Short Float21.21%EarningsMay 02/a
Analyst Recom2.43Target Price6.43
Avg Volume5.79M52W Range1.51 - 13.31
Apr-25-24 10:01AM Analysts Estimate WW International (WW) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-24 02:34AM Spotting Winners: ADT (NYSE:ADT) And Specialized Consumer Services Stocks In Q4 (StockStory)
Apr-18-24 04:01PM WW International, Inc. Schedules First Quarter 2024 Earnings Conference Call (GlobeNewswire)
Apr-11-24 09:05AM WeightWatchers Appoints New Executive Leaders (GlobeNewswire)
Apr-09-24 05:02AM Specialized Consumer Services Stocks Q4 Highlights: WW (NASDAQ:WW) (StockStory) +7.65%
Apr-08-24 05:08PM Weight Watchers Creditors Prepare to Sign Cooperation Agreement (Bloomberg) +10.24%
Apr-05-24 05:48AM Specialized Consumer Services Stocks Q4 In Review: 1-800-FLOWERS (NASDAQ:FLWS) Vs Peers (StockStory)
Mar-29-24 07:47AM Specialized Consumer Services Stocks Q4 Results: Benchmarking LKQ (NASDAQ:LKQ) (StockStory)
Mar-14-24 09:45AM Is WW Stock on the Brink of Bankruptcy? (InvestorPlace) -20.43%
Mar-12-24 10:28AM 25 Best Ways To Lose Weight That Actually Work (Insider Monkey) -6.97%
PACB - Pacific Biosciences of California Inc - Stock Price Chart
TickerPACB [NASD, RUT]
CompanyPacific Biosciences of California Inc
CountryUSA
IndustryMedical Devices
Market Cap400.25MEPS (ttm)-1.21
P/E-EPS this Y15.58%
Forward P/E-EPS next Y19.51%
PEG-EPS past 5Y-9.76%
P/S2.00EPS next 5Y-1.00%
P/B0.56EPS Q/Q-
Dividend-Sales Q/Q-0.26%
Insider Own6.08%Inst Own102.33%
Insider Trans-1.21%Inst Trans-6.40%
Short Float18.97%EarningsMay 09/a
Analyst Recom2.36Target Price4.82
Avg Volume9.79M52W Range1.25 - 14.55
Apr-25-24 09:35AM Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks (Zacks)
Apr-23-24 12:00PM Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know (Zacks) -5.77%
Apr-17-24 01:00PM PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays (Zacks)
Apr-16-24 02:47PM The Cathie Wood Stock Shuffle: 4 Names Shes Loving, 3 Shes Leaving (InvestorPlace) -50.62%
08:05AM PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance (PR Newswire)
Apr-03-24 10:54AM Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
Mar-27-24 08:00AM Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes (PR Newswire) +5.68%
Mar-22-24 04:30PM PacBio Grants Equity Incentive Award to New Employee (PR Newswire)
Mar-13-24 03:32PM 11 Oversold NASDAQ Stocks To Buy Right Now (Insider Monkey) +5.74%
10:17AM PacBio's (PACB) New Panel to Aid Its Clinical Research Solution (Zacks)
1⋯10⋯14151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.